CoChat

A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression

FEIGHNER, JOHN P., BOYER, WILLIAM F., MERIDETH, CHARLES H., HENDRICKSON, G. GORDON · 1989 · International Clinical Psychopharmacology
Cited by 58

The DOI matches its Crossref record.

Abstract

Fluoxetine is the first selective serotonin reuptake inhibitor antidepressant to be marketed in the U.S. In this double-blind trial fluoxetine was compared with imipramine and placebo among 198 outpatients with DSM-III major depression, of whom 145 completed at least 2 weeks of active treatment and were evaluated for efficacy. Significantly fewer patients in each active drug group terminated early due to lack of efficacy compared to placebo. Both imipramine and fluoxetine were significantly superior to placebo on most measures. There were no consistently significant differences between the two active drugs although a trend favored imipramine on a number of measures. Fluoxetine was generally well tolerated. Significantly more imipramine than placebo patients terminated early due to side-effects while the fluoxetine-placebo difference was not significant. The results support previous studies which suggest fluoxetine's superior side-effect profile and the approximate antidepressant equivalence of fluoxetine and TCAs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004850-198904000-00004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 58

Metadata

Authors
FEIGHNER, J. P., BOYER, W. F., MERIDETH, C. H., & HENDRICKSON, G. G.
Venue
International Clinical Psychopharmacology
Published
1989-04
Volume
4
Issue
2
Pages
127-134
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2083851787
Cited by
58
References
0
FWCI
1.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression. https://app.cochat.ai/papers/10.1097/00004850-198904000-00004
The paper
FEIGHNER, J. P., BOYER, W. F., MERIDETH, C. H., & HENDRICKSON, G. G. (1989). A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-198904000-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.